Dravet综合征-话题@MedSci

#Dravet综合征#

11篇内容 | 946人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1361272, encodeId=342013612e219, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=Dravet综合征：一种可治疗的罕见病, objectType=article, longId=735990, objectId=6951e35990af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6951e35990af, replyNumber=0, likeNumber=49, createdTime=2022-08-17, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6951e35990af, moduleTitle=Dravet综合征：一种可治疗的罕见病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6951e35990af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361271, encodeId=6f8513612e162, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=Neurology：大龄Dravet综合征患者步态和运动异常进行性恶化, objectType=article, longId=727578, objectId=b6ace27578ce, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6ace27578ce, replyNumber=0, likeNumber=45, createdTime=2022-05-24, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6ace27578ce, moduleTitle=Neurology：大龄Dravet综合征患者步态和运动异常进行性恶化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6ace27578ce)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361270, encodeId=0e6d13612e05a, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=欧盟批准Fintepla治疗Dravet综合征, objectType=article, longId=204987, objectId=e0b520498e9f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0b520498e9f, replyNumber=0, likeNumber=46, createdTime=2020-12-31, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0b520498e9f, moduleTitle=欧盟批准Fintepla治疗Dravet综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0b520498e9f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361269, encodeId=9ba31361269a2, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价, objectType=article, longId=202237, objectId=0af120223ece, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0af120223ece, replyNumber=0, likeNumber=54, createdTime=2020-10-19, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0af120223ece, moduleTitle=FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0af120223ece)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361268, encodeId=0e8f1361268aa, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=EPX-100治疗Dravet综合征：II期研究已经启动, objectType=article, longId=200907, objectId=006a20090e8e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=006a20090e8e, replyNumber=0, likeNumber=41, createdTime=2020-09-20, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=006a20090e8e, moduleTitle=EPX-100治疗Dravet综合征：II期研究已经启动, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=006a20090e8e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361267, encodeId=3903136126ef4, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=FDA批准Fintepla治疗Dravet综合征, objectType=article, longId=196569, objectId=164419656994, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=164419656994, replyNumber=0, likeNumber=43, createdTime=2020-06-28, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=164419656994, moduleTitle=FDA批准Fintepla治疗Dravet综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=164419656994)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361266, encodeId=b3a01361266be, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=JAMA Neurol：大麻二酚可降低Dravet综合征导致的抽搐发作频率, objectType=article, longId=189280, objectId=6419189280c0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6419189280c0, replyNumber=0, likeNumber=55, createdTime=2020-03-05, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6419189280c0, moduleTitle=JAMA Neurol：大麻二酚可降低Dravet综合征导致的抽搐发作频率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6419189280c0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361265, encodeId=cdc81361265b8, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=Lancet：芬氟拉明用于Dravet综合征的治疗, objectType=article, longId=184932, objectId=7181184932e1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7181184932e1, replyNumber=0, likeNumber=38, createdTime=2019-12-20, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7181184932e1, moduleTitle=Lancet：芬氟拉明用于Dravet综合征的治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7181184932e1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361264, encodeId=e6a71361264a5, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=EPX-100治疗Dravet综合征, objectType=article, longId=172182, objectId=47a41e21820d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47a41e21820d, replyNumber=0, likeNumber=39, createdTime=2019-06-27, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47a41e21820d, moduleTitle=EPX-100治疗Dravet综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47a41e21820d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361263, encodeId=3c731361263f5, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=美国为Dravet综合征提供了新的治疗方案, objectType=article, longId=147459, objectId=7b3c14e4595b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b3c14e4595b, replyNumber=0, likeNumber=43, createdTime=2018-08-28, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b3c14e4595b, moduleTitle=美国为Dravet综合征提供了新的治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7b3c14e4595b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1361262, encodeId=a7e51361262fa, content=<a href='/topic/show?id=73556238a1' target=_blank style='color:#2F92EE;'>#Dravet综合征#</a>, objectTitle=NEJM：大麻可改善Dravet综合征患者病情, objectType=article, longId=100008, objectId=f17c10000838, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f17c10000838, replyNumber=0, likeNumber=56, createdTime=2017-05-30, rootId=0, userName=zhang92560, userId=7460166, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f17c10000838, moduleTitle=NEJM：大麻可改善Dravet综合征患者病情, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f17c10000838)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

Dravet综合征

2020-05-29

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

Dravet综合征：一种可治疗的罕见病

2022-08-17

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

Neurology：大龄Dravet综合征患者步态和运动异常进行性恶化

2022-05-24

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

欧盟批准Fintepla治疗Dravet综合征

2020-12-31

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

FINTEPLA（芬氟拉明）治疗Dravet综合征的癫痫发作：CHMP持正面评价

2020-10-19

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

EPX-100治疗Dravet综合征：II期研究已经启动

2020-09-20

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

FDA批准Fintepla治疗Dravet综合征

2020-06-28

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

JAMA Neurol：大麻二酚可降低Dravet综合征导致的抽搐发作频率

2020-03-05

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

Lancet：芬氟拉明用于Dravet综合征的治疗

2019-12-20

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

EPX-100治疗Dravet综合征

2019-06-27

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

美国为Dravet综合征提供了新的治疗方案

2018-08-28

zhang92560 (审核中...)

前往app查看评论内容

#Dravet综合征#

NEJM：大麻可改善Dravet综合征患者病情

2017-05-30

科室
- - 订阅+
  - 更多科室
工具
服务